durvalumab
astrazeneca
['triplet,(-triplete)', 'durva']
excited to share data from phase 1 intratumoral injection trial of mrna-2752 (triplet il-23/il-36 /ox40l)+durvalumab dc activation t cell recruitment deep/durable responses (even non-injected lesions) in refractory tumors including #tnbc #melanoma poster #767 #sitc22 